Agilon, Baby Girl .

HRN: 23-70-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
CEFTRIAXONE 1G (VIAL)
09/10/2023
09/16/2023
IVT
580mg
OD
Pcap C; T/c Hyperbilirubinemia
Waiting Final Action 
09/10/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/10/2023
09/16/2023
IVT
90mg
OD
Pcap C; T/c Hyperbilirubinemis
Waiting Final Action 
09/13/2023
CEFTAZIDIME 1GM (VIAL)
09/13/2023
09/19/2023
IV
300mg
Q8
PCAP C
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: